-
Mashup Score: 3FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck - 1 month(s) ago
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet
FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck @PHAssociation @Merck @JNJNews #cardiology #hypertension https://t.co/K5I7meSRVW